6-K 1 ambevsacvm358jan2018_6k1.htm INDIVIDUAL FORM ambevsacvm358jan2018_6k1.htm - Generated by SEC Publisher for SEC Filing
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 6-K
 
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
 

For the month of February, 2018

Commission File Number 1565025

 

 

AMBEV S.A.
(Exact name of registrant as specified in its charter)
 

AMBEV S.A.
(Translation of Registrant's name into English)
 

Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor
04530-000 São Paulo, SP
Federative Republic of Brazil
(Address of principal executive office)
 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. 


Form 20-F ___X___ Form 40-F _______

 Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.  

Yes _______ No ___X____


 

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

 

In January 2018:

 

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002.(1)

 

(   ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

 

Company Name: Ambev S.A.

Name: Ambev S.A.

CPF/CNPJ: 07.526.557/0001-00

Qualification: Outstanding  Shares in Treasury

Initial Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

%

Same Class and Type

Total

Shares

Common

7,394,037

0.0470

0.0470

Transactions in the month

Securities / Derivatives

Securities Characteristics (2)

Intermediary

Operation

Day

Quantity

Price

Volume (R$) (3)

Shares

Common

Direct with the Company

Conversion in ADRs

02

6,602

0.00

0.00

Shares

Common

Direct with the Company

Conversion in ADRs

16

29,185

0.00

0.00

Shares

Common

Direct with the Company

Conversion in ADRs

22

211,690

0.00

0.00

Shares

Common

Direct with the Company

Conversion in ADRs

23

30,677

0.00

0.00

 

 

 

Total Conversion ADRs (Out)

 

278,154

 

0.00

Shares

Common

Direct with the Company

Exerc Options

03

30,465

11.9720

364,726.98

Shares

Common

Direct with the Company

Exerc Options

03

34,950

17.1980

601,070.10

Shares

Common

Direct with the Company

Exerc Options

05

45,175

9.3596

422,819.93

Shares

Common

Direct with the Company

Exerc Options

11

521,325

5.8720

3,061,220.40

 

 

 

Total Sell

 

631,915

 

4,449,837.41

 

 

 

 

 

 

 

 

Shares

Common

Direct with the Company

Plan of Shares Acquisition

03

44,425

21.74

965,799.50

Shares

Common

Direct with the Company

Plan of Shares Acquisition

11

157,363

21.85

3,438,381.55

 

 

 

Total Buy

 

201,788

 

4,404,181.05

Final Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

%

Same Class and Type

Total

Shares

Common

6,685,756

0.0425

0.0425

                       

 

(1)      When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

 

(2)      Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

 

(3)      Quantity multiplied by price.

 


 

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

 

In January 2018:

 

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002.(1)

 

(  ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

 

Company Name: Ambev S.A.

Name: Ambev S.A.

CPF/CNPJ: 07.526.557/0001-00

Qualification: Outstanding  Shares in Treasury

Initial Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

%

Same Class and Type

Total

ADR (*)

Common

0

0.0000

0.0000

Transactions in the month

Securities / Derivatives

Securities Characteristics (2)

Intermediary

Operation

Day

Quantity

Price USD

Volume (USD) (3)

ADR (*)

Common

Direct with the Company

Conversion in ADRs

02

6,602

0.00

0.00

ADR (*)

Common

Direct with the Company

Conversion in ADRs

16

29,185

0.00

0.00

ADR (*)

Common

Direct with the Company

Conversion in ADRs

22

211,690

0.00

0.00

ADR (*)

Common

Direct with the Company

Conversion in ADRs

23

30,677

0.00

0.00

 

 

 

Total Conversion ADRs (In)

 

278,154

 

0.00

 

 

 

 

 

 

 

 

ADR (*)

Common

Direct with the Company

Plan of Shares Acquisition

02

33,848

6.61

223,737.04

ADR (*)

Common

Direct with the Company

Plan of Shares Acquisition

16

14,590

6.75

98,485.07

ADR (*)

Common

Direct with the Company

Plan of Shares Acquisition

22

360,920

6.80

2,454,252.94

ADR (*)

Common

Direct with the Company

Plan of Shares Acquisition

23

26,248

6.71

176,125.95

 

 

 

Total Buy

 

435,606

 

2,952,601.00

 

 

 

 

 

 

 

 

ADR (*)

Common

Direct with the Company

Exerc Options

02

40,450

5.5312000

223,737.04

ADR (*)

Common

Direct with the Company

Exerc Options

16

19,050

1.1541166

21,985.92

ADR (*)

Common

Direct with the Company

Exerc Options

16

24,725

3.0940000

76,499.15

ADR (*)

Common

Direct with the Company

Exerc Options

22

44,050

3.0940000

136,290.70

ADR (*)

Common

Direct with the Company

Exerc Options

22

34,050

1.6760000

57,067.80

ADR (*)

Common

Direct with the Company

Exerc Options

22

110,750

2.8628000

317,055.10

ADR (*)

Common

Direct with the Company

Exerc Options

22

76,250

3.8416000

292,922.00

ADR (*)

Common

Direct with the Company

Exerc Options

22

91,325

5.5312000

505,136.84

ADR (*)

Common

Direct with the Company

Exerc Options

22

216,185

5.3000000

1,145,780.50

ADR (*)

Common

Direct with the Company

Exerc Options

23

56,925

3.0940000

176,125.95

 

 

 

Total Sell

 

713,760

 

2,952,601.00

 

 

 

 

 

 

 

 

Final Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

%

Same Class and Type

Total

ADR (*)

Common

0

0.0000

0.0000

                       

 

(1)      When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.  

(2)      Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3)      Quantity multiplied by price.

(*)    Each ADR is equivalent to 1 (one) share.


 

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

 

In January 2018:

 

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002.(1)

 

(  ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

 

Subsidiary Name: Ambev Luxembourg S.À.R.L.

Qualification: Position – Total Return Swap

Transactions in the month

Securities / Derivatives

Securities Characteristics (1)

Intermediary

Operation

Day

Quantity (**)

Price USD

Volume (USD) (2)

Swap

Swap referenced in Shares

N/A

Total Return Swap Conclusion

24 (*)

925,000

21.7825

20,148,812.50

Swap

Swap referenced in Shares

N/A

Total Return Swap Conclusion

26 (*)

356,500

21.8255

7,780,790.75

Swap

Swap referenced in Shares

N/A

Total Return Swap Conclusion

29 (*)

1,058,000

21.7874

23,051,069.20

 

 

 

Total operation

 

2,339,500

 

50,980,672.45

 

(1)      Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

 

(2)      Quantity multiplied by price.

 

 

(*) In accordance with the Circular Letter/CVM/SEP/Nº07/2017, date information of the total return swap conclusion and not the date of the financial settlement of the transaction.

 

(**) The reported quantity is not actually related to a purchase or sale, but an economic exposure arising from the conclusion of a swap agreement on a consolidated basis, in accordance with the Circular Letter/CVM/SEP/Nº07/2017.

 

 

 

 

 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
Date: February 9, 2018
     
 
AMBEV S.A.
     
 
By: 
/s/ Ricardo Rittes de Oliveira Silva
 
Ricardo Rittes de Oliveira Silva
Chief Financial and Investor Relations Officer